GB9610365D0 - Compounds and methods for selectively inhibiting activation of the human A3 adenosine receptor - Google Patents

Compounds and methods for selectively inhibiting activation of the human A3 adenosine receptor

Info

Publication number
GB9610365D0
GB9610365D0 GBGB9610365.0A GB9610365A GB9610365D0 GB 9610365 D0 GB9610365 D0 GB 9610365D0 GB 9610365 A GB9610365 A GB 9610365A GB 9610365 D0 GB9610365 D0 GB 9610365D0
Authority
GB
United Kingdom
Prior art keywords
compounds
human
methods
adenosine receptor
selectively inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9610365.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to GBGB9610365.0A priority Critical patent/GB9610365D0/en
Publication of GB9610365D0 publication Critical patent/GB9610365D0/en
Priority to PCT/US1997/003648 priority patent/WO1997033879A1/en
Pending legal-status Critical Current

Links

GBGB9610365.0A 1996-03-15 1996-05-17 Compounds and methods for selectively inhibiting activation of the human A3 adenosine receptor Pending GB9610365D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB9610365.0A GB9610365D0 (en) 1996-05-17 1996-05-17 Compounds and methods for selectively inhibiting activation of the human A3 adenosine receptor
PCT/US1997/003648 WO1997033879A1 (en) 1996-03-15 1997-03-11 Compounds and methods for selectively inhibiting activation of the human a3 adenosine receptor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9610365.0A GB9610365D0 (en) 1996-05-17 1996-05-17 Compounds and methods for selectively inhibiting activation of the human A3 adenosine receptor

Publications (1)

Publication Number Publication Date
GB9610365D0 true GB9610365D0 (en) 1996-07-24

Family

ID=10793883

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9610365.0A Pending GB9610365D0 (en) 1996-03-15 1996-05-17 Compounds and methods for selectively inhibiting activation of the human A3 adenosine receptor

Country Status (1)

Country Link
GB (1) GB9610365D0 (en)

Similar Documents

Publication Publication Date Title
EP1019100A4 (en) Controlled release of substances
GB2347867B (en) Flushable release liners and methods of making the same
PL328822A1 (en) Human bikinine
SI0938318T1 (en) Tablet with controlled release of alfuzosine chlorydrate
GB9507984D0 (en) Inhibition of eosinophil activation through A3 adenosine receptor antagonism
IL129083A0 (en) Methods and compounds for inhibiting beta-amyloid peptide release and/or its synthesis
ZA97209B (en) Substituted aza- and diacycloheptane and -cyclooctane compounds and their use
IL136308A0 (en) Antipicornaviral compounds and methods for their use and preparation
EP0828751A4 (en) Human neuropeptide receptor
GB9616594D0 (en) System for the realization of adjustable size composed elements
PL328335A1 (en) Acyclic derivatives of nucleosides
AU132985S (en) Lavatory
GB9607441D0 (en) Human hyaluronan receptor
EP0792282A4 (en) Human endothelin-bombesin receptor
HUP0001792A3 (en) Dibenzo-oxazepine and-dioxepine derivatives and their use as anti-tumor agents
GB9610365D0 (en) Compounds and methods for selectively inhibiting activation of the human A3 adenosine receptor
GB9618429D0 (en) Adjustable seat
PT1011678E (en) Use of mecamylamine for the treatment of nicotine-responsive neuropsychiatric disorders
GB9616590D0 (en) A method for inhibiting activation of the human A3 adenosine receptor
GB9603451D0 (en) A method for inhibiting activation of the human A3 adenosine receptor
GB9626441D0 (en) A method for inhibiting activation of the human A3 adenosine receptor
GB9625079D0 (en) Personal shower system
GB9617346D0 (en) Therapeutic methods and compositions for use therein
AU135498S (en) Lavatory
ZA948394B (en) Human endothelin-bombesin receptor